
    
      Investigators plan to enroll up to 100 eligible participants in this pilot trial with 50
      participants randomized to receive melatonin and 50 patients randomized to receive a placebo.
      Participants will be randomized on a rolling basis; meaning, once participants agree to
      enroll in the study, the participant will be placed randomly into either group.
    
  